Commentary
Commentary
Learn more about how competition can lower premiums
Competition Is The Cure For Rising Health Insurance Premiums
The presidential election is just a week away. And the rising prices of many products and services are on voters’ minds. Just over 40% of Americans say inflation is their biggest concern heading into November, according to a recent survey. In few markets are rising prices more apparent than in ...
Sally C. Pipes
October 28, 2024
Classroom Ideology
Learn more about the math and literacy crisis
Dr. Lance Izumi On Why Kids Can’t Read or Do Math
Dr. Lance Izumi, senior director of the Pacific Research Institute’s Center for Education, recently wrote “The Great Classroom Collapse.” The book centers around a fundamental question: Why can’t kids today read or do math? In an attempt to answer that question, “The Great Classroom Collapse” is divided into three sections: ...
Lance Izumi
October 23, 2024
calrecycle
Learn more about recycling hypocrisy
AG Bonta’s Recycling Hypocrisy Will Harm Consumers
California’s Attorney General Rob Bonta is suing ExxonMobil over accusations of deception. Allegedly, the company deceived Californians for nearly 50 years “by promising that recycling could and would solve the ever-growing plastic waste crisis,” even though ExxonMobil knew that it could never handle “more than a tiny fraction of the ...
Wayne H Winegarden
October 23, 2024
Commentary
Learn more about how government intervention is harming the healthcare market
Trump vs. Harris on Health Care: Experts Explain Each Side
“He and his colleagues believe that patients are not in control of the health care system and that we suffer from an opaque and complex pricing structure that harms patients. “Winegarden’s free market approach means he advocates for doing away with the Obamacare subsidies that Congress must consider, as they ...
Wayne H Winegarden
October 23, 2024
Commentary
Learn more about how price controls hurt patients
Harris’s Home Care Promises Unworkable, Unwise
U.S. Vice President Kamala Harris’s new proposal to provide subsidized at-home care for seniors through Medicare has received a warm reception from many academics and advocates for the elderly. But the likely cost of this new plan — not just to taxpayers but to the health of patients both present and future ...
Sally C. Pipes
October 22, 2024
Commentary
Learn more about escalating healthcare costs
Medicare should not cover at-home care
Vice President Kamala Harris announced a plan earlier this month to add home healthcare benefits to Medicare. The plan is a fiscal fantasy. Medicare is already in a fiscal crisis, and new benefits will only make things worse. According to the Brookings Institution, covering seniors’ home care for even one year would cost Medicare $40 billion. The program ...
Sally C. Pipes
October 21, 2024
Business & Economics
Learn more about LNG exports
The High Costs Of Obstructing LNG Exports
Thanks to plentiful natural gas, consumers have access to affordable and reliable electricity, an often preferred heating/cooking fuel, and an energy source that has helped reduce U.S. greenhouse gas emissions. Greater use of natural gas is also consistent with the strong preference of “American voters across demographics and partisanship” for “an ‘all of ...
Wayne H Winegarden
October 18, 2024
Commentary
Learn more about health care reform
What Trump’s health care plan could look like
Former President Donald Trump has been jeered for saying he has “concepts of a plan” for repealing and replacing Obamacare. But that’s not quite fair. Trump’s first term in office suggests that he favors market-based reforms that increase patients’ choices. With just under a month until the election, it’s time ...
Sally C. Pipes
October 17, 2024
Commentary
Learn more about how price fixing stifles innovation
New Schizophrenia Drug Represents Promise Of Pharmaceutical Innovation
Late last month, the U.S. Food and Drug Administration approved Bristol Myers Squibb’s KarXT, a treatment for schizophrenia. The drug, which will be marketed under the brand name Cobenfy, is promising not just because it is effective at treating the debilitating mental health condition. It also seems not to have the potentially harmful side ...
Sally C. Pipes
October 15, 2024
Commentary
Learn more about healthcare reform
Vance’s Critics Wrong: No Need to Fear High-Risk Pools
Following the recent vice-presidential debate, Sen. J.D. Vance, R-Ohio, continues to face attacks on his ideas for covering people with pre-existing conditions. Vance’s critics call his proposal — which would separate out sicker patients into a separate high-risk insurance pool — inhumane and impractical. As Arthur Caplan, the head of medical ethics at NYU ...
Sally C. Pipes
October 15, 2024
Learn more about how competition can lower premiums
Competition Is The Cure For Rising Health Insurance Premiums
The presidential election is just a week away. And the rising prices of many products and services are on voters’ minds. Just over 40% of Americans say inflation is their biggest concern heading into November, according to a recent survey. In few markets are rising prices more apparent than in ...
Learn more about the math and literacy crisis
Dr. Lance Izumi On Why Kids Can’t Read or Do Math
Dr. Lance Izumi, senior director of the Pacific Research Institute’s Center for Education, recently wrote “The Great Classroom Collapse.” The book centers around a fundamental question: Why can’t kids today read or do math? In an attempt to answer that question, “The Great Classroom Collapse” is divided into three sections: ...
Learn more about recycling hypocrisy
AG Bonta’s Recycling Hypocrisy Will Harm Consumers
California’s Attorney General Rob Bonta is suing ExxonMobil over accusations of deception. Allegedly, the company deceived Californians for nearly 50 years “by promising that recycling could and would solve the ever-growing plastic waste crisis,” even though ExxonMobil knew that it could never handle “more than a tiny fraction of the ...
Learn more about how government intervention is harming the healthcare market
Trump vs. Harris on Health Care: Experts Explain Each Side
“He and his colleagues believe that patients are not in control of the health care system and that we suffer from an opaque and complex pricing structure that harms patients. “Winegarden’s free market approach means he advocates for doing away with the Obamacare subsidies that Congress must consider, as they ...
Learn more about how price controls hurt patients
Harris’s Home Care Promises Unworkable, Unwise
U.S. Vice President Kamala Harris’s new proposal to provide subsidized at-home care for seniors through Medicare has received a warm reception from many academics and advocates for the elderly. But the likely cost of this new plan — not just to taxpayers but to the health of patients both present and future ...
Learn more about escalating healthcare costs
Medicare should not cover at-home care
Vice President Kamala Harris announced a plan earlier this month to add home healthcare benefits to Medicare. The plan is a fiscal fantasy. Medicare is already in a fiscal crisis, and new benefits will only make things worse. According to the Brookings Institution, covering seniors’ home care for even one year would cost Medicare $40 billion. The program ...
Learn more about LNG exports
The High Costs Of Obstructing LNG Exports
Thanks to plentiful natural gas, consumers have access to affordable and reliable electricity, an often preferred heating/cooking fuel, and an energy source that has helped reduce U.S. greenhouse gas emissions. Greater use of natural gas is also consistent with the strong preference of “American voters across demographics and partisanship” for “an ‘all of ...
Learn more about health care reform
What Trump’s health care plan could look like
Former President Donald Trump has been jeered for saying he has “concepts of a plan” for repealing and replacing Obamacare. But that’s not quite fair. Trump’s first term in office suggests that he favors market-based reforms that increase patients’ choices. With just under a month until the election, it’s time ...
Learn more about how price fixing stifles innovation
New Schizophrenia Drug Represents Promise Of Pharmaceutical Innovation
Late last month, the U.S. Food and Drug Administration approved Bristol Myers Squibb’s KarXT, a treatment for schizophrenia. The drug, which will be marketed under the brand name Cobenfy, is promising not just because it is effective at treating the debilitating mental health condition. It also seems not to have the potentially harmful side ...
Learn more about healthcare reform
Vance’s Critics Wrong: No Need to Fear High-Risk Pools
Following the recent vice-presidential debate, Sen. J.D. Vance, R-Ohio, continues to face attacks on his ideas for covering people with pre-existing conditions. Vance’s critics call his proposal — which would separate out sicker patients into a separate high-risk insurance pool — inhumane and impractical. As Arthur Caplan, the head of medical ethics at NYU ...